STARTUP PROFILE

BRAIN.Q

COUNTRY
Israel
FOUNDED
2016
CATEGORY
Tools and Infrastructure
Developing non-invasive, AI-driven neuromodulation systems to promote neuroplasticity and functional recovery after neurological injury.
Visit website →
Neurofounders Insights
$   Funding   -
Series B
MODALITY
Software
FORM FACTOR
Software/app
INTERFACE DEPTH
Non-invasive
INDICATION
Stroke
TARGET USER
Clinicians
REGULATORY STAGE
CE-Marked
BRAIN.Q is differentiated by its AI-personalized electromagnetic field therapy approach to post-stroke recovery, where stimulation parameters are tailored to individual neural network patterns rather than delivered at fixed protocols. With CE marking, Phase 2 data showing a threefold improvement in functional independence, and Series B funding, it sits among the more clinically advanced non-invasive stroke-recovery platforms.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
7
Measuring What Works
4 August – 18 August 2026

BrainQ published a study in NeuroImage: Clinical testing whether two EEG measures can track how well a stroke patient is recovering. After a stroke, the brain shifts toward slow-wave activity, and the delta/alpha and theta/alpha ratios capture how pronounced that shift is. Across 21 patients in a sham-controlled trial of its electromagnetic network targeting field therapy, patients on active treatment showed steeper declines in both ratios, consistent with recovery. The authors describe the findings as exploratory, a signal that would need a trial with pre-specified endpoints to confirm.

Articles featuring
BRAIN.Q
No items found.